我院自1995年12月以来,进行大剂量欧耐特(rhIL—Ⅱ)治疗恶性肿瘤及恶性胸腹水的临床试验,现已应用17例,小结如下。 资料与方法 1.一般资料:17例病例中,男性12例,女性5例。年龄11～70岁,中位数56岁。其中,肝癌4例,胃、肺、胰腺、胆总管、鼻咽癌各1例、慢粒急变1例、乳腺转移癌1例、切口 Since December 1995, our hospital has conducted clinical trials of large doses of rhIL-II in the treatment of malignant tumors and malignant hydrothorax and ascites. 17 cases have been applied. The summary is as follows. Materials and Methods 1. General information: Of the 17 cases, 12 were males and 5 were females. Age 11 to 70 years, median 56 years old. Among them, 4 cases of hepatocellular carcinoma, 1 case of stomach, lung, pancreas, common bile duct, nasopharyngeal carcinoma, 1 case of chronic severe transformation, 1 case of metastatic breast cancer, and incision